Eleven-Year Prognostic Value of Dobutamine Stress 99mTc-Sestamibi Myocardial Perfusion Imaging in Patients With Limited Exercise Capacity

被引:12
|
作者
Boiten, Hendrik J. [1 ]
van Domburg, Ron T. [1 ]
Valkema, Roelf [2 ]
Schinkel, Arend F. L. [1 ]
机构
[1] Erasmus MC, Thoraxctr, Dept Cardiol, Rotterdam, Netherlands
[2] Erasmus MC, Thoraxctr, Dept Nucl Med, Rotterdam, Netherlands
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2015年 / 115卷 / 07期
关键词
CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; RISK STRATIFICATION; SESTAMIBI SPECT;
D O I
10.1016/j.amjcard.2015.01.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myocardial perfusion single-photon emission computed tomography is a routine technique for the evaluation of coronary artery disease. However, information on the very long term prognostic value of dobutamine stress single-photon emission computed tomographic myocardial perfusion imaging (MPI) in patients with limited exercise capacity is scarce. The aim of this study was to assess the long-term prognostic value of dobutamine stress technetium-99m (Tc-99m) sestamibi MPI in these patients. The study population consisted of a high-risk cohort of 531 consecutive patients with limited exercise capacity who underwent dobutamine stress Tc-99m-sestamibi MPI for the assessment of known or suspected coronary artery disease. Follow-up was successful in 528 patients. Because of early revascularization, 55 patients were excluded. The present data are based on 473 patients. The end points were all-cause mortality, cardiac death, nonfatal myocardial infarction, and late (>60 days) coronary revascularization. Kaplan-Meier survival curves were performed and univariate and multivariate analyses were performed to identify predictors of very long term outcome. The mean age of the patients was 61 +/- 12 years, and 58% were men. Abnormal results (defined as the presence of reversible or fixed defects) were observed in 312 patients (66%). During a mean follow-up period of 11.3 +/- 6.7 years, 287 patients (61%) died (all-cause mortality), of whom 125 (26%) died due to cardiac causes. Nonfatal myocardial infarction occurred in 59 patients (12%). Late coronary revascularization was performed in 61 patients (13%). Univariate predictors of major cardiac events included age, male gender, previous infarction, diabetes mellitus, history of angina, heart failure, ST-segment changes, abnormal results on Tc-99m-sestamibi scan, reversible defect, fixed defect, summed rest score, and summed stress score. Multivariate analysis identified abnormal results on MPI as a strong independent predictor of major adverse cardiac events. In conclusion, in patients with limited exercise capacity, dobutamine stress Tc-99m-sestamibi single-photon emission computed tomography provides incremental prognostic information in addition to clinical and stress test parameters for the prediction of very long term outcomes. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:884 / 889
页数:6
相关论文
共 50 条
  • [41] Concordance between regadenoson stress echocardiography and miocardial perfusion study (99mTc-sestamibi) in the diagnosis of myocardial ischemia
    Sevilla, A.
    Vara, J.
    Iglesias, I.
    Rodriguez, E.
    Felix, C.
    Lastra, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S367 - S367
  • [42] PROGNOSTIC VALUE OF NORMAL TC-99M SESTAMIBI MYOCARDIAL PERFUSION IMAGING
    BROWN, KA
    ALTLAND, E
    ROWEN, M
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P54 - P54
  • [43] What is this image? 2021: Image 5 resultProgression of myocardial ischemia to scar on serial 99mTc-sestamibi myocardial perfusion imaging
    Vedran Oruc
    Ayman A. Farag
    Fadi G. Hage
    Journal of Nuclear Cardiology, 2021, 28 : 399 - 403
  • [44] Prognostic stratification of obese patients by stress 99mTc-tetrofosmin myocardial perfusion imaging
    Elhendy, Abdou
    Schinkel, Arend F. L.
    van Domburg, Ron T.
    Bax, Jeroen J.
    Valkema, Roelf
    Biagini, Elena
    Poldermans, Don
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (08) : 1302 - 1306
  • [45] Prognostic stratification of elderly patients unable to perform exercise tests using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT
    Schinkel, AFI
    Elhendy, A
    Biagini, E
    van Domburg, RI
    Valkema, R
    Rizzello, V
    Pedone, C
    Krenning, BJ
    Smoons, ML
    Poldermans, D
    Bax, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 285A - 285A
  • [46] Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing
    Schinkel, AFL
    Elhendy, A
    Biagini, E
    van Domburg, RT
    Valkema, R
    Rizello, V
    Pedone, C
    Simoons, M
    Bax, JJ
    Poldermans, D
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (01) : 12 - 18
  • [47] Prognostic value of technetium-99m sestamibi gated SPECT imaging with dobutamine stress
    Fowler, MS
    Katten, DM
    Mather, JF
    Ahlberg, AW
    McGill, CC
    Hudson, W
    Johnson, LL
    Heller, GV
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 437A - 438A
  • [48] Prognostic value of exercise stress myocardial perfusion imaging in patients with permanent pacemakers
    Lapeyre, AC
    Poornima, IG
    Miller, TD
    Hodge, DO
    Christian, TF
    Gibbons, RJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (06): : 811 - 814
  • [49] Effect of attenuation correction on the interpretation of 99mTc-sestamibi myocardial perfusion scintigraphy: the impact of 1 year's experience
    Riemer H. J. A. Slart
    Tjin H. Que
    Dirk J. van Veldhuisen
    Lieke Poot
    Paul K. Blanksma
    D. Albert Piers
    Pieter L. Jager
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1505 - 1509
  • [50] Effect of attenuation correction on the interpretation of 99mTc-sestamibi myocardial perfusion scintigraphy:: the impact of 1 year's experience
    Slart, RHJA
    Que, TH
    van Veldhuisen, DJ
    Poot, L
    Blanksma, PK
    Piers, DA
    Jager, PL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) : 1505 - 1509